We have previously shown that HPR increases Cer levels in HTLV-1 negative leukemia cells, but not in HTLV-1 transformed cells, concomitant with lower sensitivity of HTLV-1 positive cells to treatment with exogenous C2- and C6-Cer. The gene discussed is CBLN1; the disease is leukemia.